FeesSafety
Pluang+

Leads Biolabs' Opamtistomig enters Phase II expansion for first-line gastric cancer treatment

Market News
20 Oct 2026, 13:18 WIB
Globe News Wire
View Source
Bullish
Leads Biolabs' Opamtistomig enters Phase II expansion for first-line gastric cancer treatment

Leads Biolabs announced that its PD-L1/4-1BB bispecific antibody, Opamtistomig, has advanced to the expansion stage in a Phase II trial for first-line treatment of advanced gastric cancer. This stage will compare Opamtistomig plus chemotherapy directly with the current standard, tislelizumab plus chemotherapy, aiming to improve outcomes especially for patients with low PD-L1 expression who respond poorly to existing therapies. The study, led by Peking University Cancer Hospital, seeks to identify patient groups most likely to benefit and could offer a new, more effective immunotherapy option for this challenging cancer type. Opamtistomig's unique mechanism activates T cells regardless of PD-L1 levels, potentially overcoming limitations of current treatments.

Leads Biolabs' Opamtistomig development is noted alongside Health-sector market activity on Pluang. For readers following Health stocks, here is Pluang's market snapshot as of Oct 20, 2026 17:01 WIB: out of 150 priced Health-sector US stocks, 78 rose and 62 fell. Notable movers include AstraZeneca plc (AZN) at USD 166.85 with a Pluang order activity of 13% Sell / 87% Buy and a typical hold time of 126 Days, Tango Therapeutics Inc. (TNGX) at USD 23.10 with a 1-day change of -1.83%, and Nuvation Bio Inc. Class A (NUVB) at USD 4.40 with a 1-day change of -1.79%.

More News

Jyske Bank buys back shares worth DKK 2.39 billion, holding 4.22% treasury shares as of November 2026

Jyske Bank buys back shares worth DKK 2.39 billion, holding 4.22% treasury shares as of November 2026

Jyske Bank has been actively repurchasing its shares under a program running from February 2026 to January 2027, acquiring shares worth up to DKK 3 billion. As of mid-November 2026, the bank has bought back shares valued at approximately DKK 2.39 bil...

Company Fundamentals
Neutral
1 hour ago
Jyske Bank buys back 2.45M shares worth DKK 2.39B, owning 4.22% of its stock by Nov 2026.

Jyske Bank buys back 2.45M shares worth DKK 2.39B, owning 4.22% of its stock by Nov 2026.

Jyske Bank is conducting a share buyback program running from February 5, 2026, to January 29, 2027, with a maximum value of DKK 3 billion. As of mid-November 2026, the bank has repurchased 2,453,745 shares at an average price of DKK 974.50 per share...

Company Fundamentals
Bullish
1 hour ago
Chinese beauty innovation shines at 2026 INPD in Paris with OSM winning top RMB 1M award

Chinese beauty innovation shines at 2026 INPD in Paris with OSM winning top RMB 1M award

The 2026 International Cosmetics Innovation Summit and Awards (INPD) was held in Paris, showcasing Chinese beauty companies' innovations under the theme "REGENERATIONS." Sixteen Chinese brands received awards for breakthroughs in ingredients, formula...

Bullish
1 hour ago
OrdoAI launches Ordo Brand AI tool to streamline global marketing with creator partnerships, public release in Q1 2027.

OrdoAI launches Ordo Brand AI tool to streamline global marketing with creator partnerships, public release in Q1 2027.

OrdoAI, a company specializing in AI-driven global marketing, is expanding into AI product development with its first AI agent, Ordo Brand. This tool helps brands and agencies manage creator partnerships across markets by simplifying discovery, outre...

Others
Bullish
2 hours ago
Binance's Ether spot order book shows $3.7M bid lead at $1,812.51, indicating strong buying interest.

Binance's Ether spot order book shows $3.7M bid lead at $1,812.51, indicating strong buying interest.

On November 16, Binance's Ether (ETH) spot order book revealed a $3.7165 million bid lead with Ether priced at $1,812.51. Total bids amounted to $11.49 million compared to $7.77 million in asks, showing stronger buying interest in the spot market. Bi...

Technical Signals
Neutral
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App